Home / Health / Operation Warp Speed ​​is vaccine ready as the CDC tries to manage expectations

Operation Warp Speed ​​is vaccine ready as the CDC tries to manage expectations



Operation Warp Speed ​​is gearing up for full-scale distribution of a potential vaccine, including with state and community-specific guidelines, though top public health officials say widely available inoculation likely won̵

7;t be ready for the general public before 2021.

vaccine distribution strategy, which strengthens a vaccine timing in sync with what health officials have said likely – in January 2021 or sometime later – rather than President Donald Trump’s more aggressive outlook. “data-reactid =” 17 “> The US Department of Health and Human Services (HHS) shared its vaccine distribution strategy, which strengthens a timeline of vaccines in sync with what health officials have said is likely – in January 2021 or sometime later – rather than President Donald Trump’s more aggressive prospects.

Paul Mango, Deputy Chief of Staff for Policy at the Department of Health and Human Services, told Bloomberg News on Wednesday that all Americans should be able to access a recovery by April 2021 – a more realistic timeframe being filmed. by Dr Anthony Fauci and Centers for Robert Redfield, director of Disease Control (CDC), who spoke to a Senate panel on Wednesday. He added that the United States can expect to resume “normal life” in the second half of next year.

Redfield noted that small-scale vaccinations could begin by November or December and increase, and it takes “six to nine months to vaccinate the American public.”

regarding relationships that he and his staff attempted to interfere with the CDC’s dissemination of information about the pandemic. “data-reactid =” 24 “> Political pressure has played a role in the confusion and growing skepticism about a safe and effective vaccine. A Trump ally, Michael Caputo, who has been the main spokesperson for HHS, is taking a leave of 60 days following reports that he and his staff attempted to interfere in the dissemination of information about the pandemic from the CDC.

a more detailed playbook, including a look at different states, territories and tribal communities for vaccine distribution. In a call with reporters, officials said the federal government would be ready to distribute the vaccines within 24 hours of being authorized for emergency use or a application for an organic license by the US Food and Drug Administration (FDA). “data-reactid =” 25 “> But the CDC continued to share its data and continued on Wednesday to share a more detailed playbook, including a look at different states, territories and tribal communities for vaccine distribution. With reporters, officials said the federal government would be ready to distribute the vaccines within 24 hours of an emergency use permit or biological license application from the U.S. Food and Drug Administration (FDA).

Redfield noted that the company chosen to distribute the vaccine, McKesson (MCK), already works with the federal government to distribute 80 million doses of influenza and other vaccinations each year and aims to scale up to 900 million doses.

launch of a $ 16 million tracking system to help with the supplies, distribution, and administration of the COVID-19 vaccine, but some say the effort conflicts with existing state-level tracking systems. “data-reactid =” 27 “> In line with this effort, the Trump administration is launching a $ 16 million tracking system to help with the supplies, distribution and administration of the COVID-19 vaccine, but some say that the effort conflicts with existing state-level tracking systems.

MRNA) and Pfizer (PFE) with BioNTech (BNTX) to conclude Phase 3 trials. Pfizer recently held an Investor Day event and noted that it is on track to deliver efficacy results by the end of October. “Data-reactid =” 28 “> The country is waiting for its leaders, including Moderna (MRNA) and Pfizer (PFE) with BioNTech (BNTX) to conclude phase 3 trials. Pfizer recently organized an investor day event and noted that it is on track to deliver effective results by the end of October.

In a note from an analyst, SVB Leerink noted that the company has a supply of 100 million doses by the end of the year and has pledged to supply 450 million doses. Overall, Pfizer is in talks to deliver up to 600 million – or 1 billion in total – within the next year.

Pfizer “is now grossly overfed for its original efficacy assumptions, and with 29,000 subjects enrolled and more than 12,000 having had two doses, the signal of efficacy could really come overnight,” according to the note.

There are over 6.5 million cases in the United States (Graph: David Foster / Yahoo Finance)

But in the meantime, antibody treatments have been increasingly in the spotlight as the reality of widespread vaccine use looks to mid-2021. Using the blood from recovered patients and the antibodies contained in them was an approach. promising and apparently low-risk to tackle the global pandemic.

LLY) provided a promising update On Wednesday, showing his antibody treatment resulted in reducing the amount of the virus in a person’s body, thus avoiding ventilators and death in a limited group of the population. “Data-reactid =” 56 “> To this end, Eli Lilly (LLY) provided a promising update on Wednesday showing that his antibody treatment led to reducing the amount of virus in a person’s body, thus avoiding ventilators and death in a limited group of the population.

Daniel Skovronsky, scientific director of Lilly and president of Lilly Research Laboratories, said the findings “reinforce our belief that neutralizing antibodies can help in the fight against COVID-19.”

REGN), which is also working on an antibody cocktail. “data-reactid =” 58 “> The news is a positive sign for others like Regeneron (REGN), which is also working on an antibody cocktail.

There are over 29 million cases around the world. (Graphics: David Foster / Yahoo Finance)

NVAX) are pursuing the same goal. “data-reactid =” 79 “> Growing global concern about the ongoing pandemic has prompted several vaccine companies to focus their efforts on fair global distribution. even smaller new competitors like Moderna and Novavax (NVAX) they are pursuing the same goal.

an office in Switzerland, a country that has been optimistic about Moderna’s vaccine candidate and where the company’s main high-volume production partner, Lonza, is based. The Swiss federal government is purchasing 4.5 million doses of Moderna’s candidate. “Data-reactid =” 80 “> Recently, Novavax announced a relationship with the Serum Institute of India, while Moderna on Wednesday said it was paving the way for an office in Switzerland, a country that has been optimistic about Moderna’s vaccine candidate. and where the company’s main high-volume manufacturing partner, Lonza, is based.The Swiss federal government is purchasing 4.5 million doses of Moderna’s candidate.

see new peaks in positive diagnoses. Those countries had decided to open up before Italy and Spain, which were the hotspots in Europe, include the Czech Republic and France. “Data-reactid =” 81 “> Meanwhile, Europe is struggling to manage the recurrence of the coronavirus epidemic in parts that has reopened, but are now seeing new peaks of positive diagnoses. These countries had decided to open before Italy and Spain, which were the hotspots in Europe, include the Czech Republic and France.

Read the latest financial and business news from Yahoo Finance“data-reactid =” 88 “>Read the latest financial and business news from Yahoo Finance

Twitter, & nbsp;Facebook, & nbsp;Instagram, & nbsp;Flipboard, & nbsp;SmartNews, & nbsp;LinkedIn, & nbsp;Youtube.“data-reactid =” 89 “>Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, SmartNews, LinkedIn, Youtube.




Source link